Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases

Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis. Specifically for pediatric acute liver failure, they account for 10–15% of cases, with a mortality of 22–65%. The percentage of acute liver failure caused...

Full description

Saved in:
Bibliographic Details
Published in:Molecular genetics and metabolism 2019-06, Vol.127 (2), p.117-121
Main Authors: Ferreira, Carlos R., Cassiman, David, Blau, Nenad
Format: Article
Language:eng
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis. Specifically for pediatric acute liver failure, they account for 10–15% of cases, with a mortality of 22–65%. The percentage of acute liver failure caused by an inherited metabolic disease in children
ISSN:1096-7192
1096-7206